DekaBank Deutsche Girozentrale
TNDM icon

DekaBank Deutsche Girozentrale’s Tandem Diabetes Care TNDM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,000
Closed -$1.58M – 1404
2022
Q3 		$1.58M Buy
32,000
+6,000
+23% +$329K ﹤0.01% 764
2022
Q2 		$1.56M Buy
+26,000
New +$2.13M ﹤0.01% 775

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TNDM Position: Q4 2022 in Review

DekaBank Deutsche Girozentrale sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 32,000 shares — an estimated $1.58M sold.

DekaBank Deutsche Girozentrale first reported a position in TNDM in Q2 2022 and held it in 2 quarters. The position peaked at $1.58M in Q3 2022. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 32,000 Tandem Diabetes Care shares in Q4 2022, an estimated $1.58M.
  • DekaBank Deutsche Girozentrale first reported a position in Tandem Diabetes Care in Q2 2022 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Tandem Diabetes Care position peaked at $1.58M in Q3 2022.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.